Extended Lipid Panel Assay
Enzymatic Esterase--Oxidase, Cholesterol. 510(k) K181373, from Laboratory Corporation of America Holdings (Morrisville, NC). Product code CHH, class 1.
As of Nov 19, 2026, K181373 is an FDA 510(k) held by Laboratory Corporation of America Holdings, substantially equivalent on Oct 18, 2018 after 147 days, with no recalls tied to it in FDA's recall database.
- Review time: 147 days
- Recalls: 0
The Extended Lipid Panel Assay is an in vitro diagnostic test for quantitative determination of Total Cholesterol, High Density Lipoprotein Cholesterol, and Triglycerides in human serum and plasma, and Apolipoprotein B in human serum. Values for Total Cholesterol, High Density Lipoprotein Cholesterol, Triglycerides and Apolipoprotein B are calculated by the Vantera® Clinical Analyzer.
- Modification To:Cobas Integra Hdl-Cholesterol Plus 2ND GenerationK012286 · Roche Diagnostics Corp. · Aug 8, 2001
- Cobas Integra Cholesterol Gen. 2K031824 · Roche Diagnostics Corp. · Jul 9, 2003
- Triglycerides Gpo Without Free GlycerolK873049 · Boehringer Mannheim Corp. · Aug 28, 1987
- Dimension Vista APOA1 and Apob Flex Reagent Cartridges and Protein 1 Calibrator and Control Medium and HighK063608 · Dade Behring, Inc. · Feb 23, 2007
- Tina-Quant Apolipoprotein B VER.2K013206 · Roche Diagnostics Corp. · Nov 16, 2001
- LipidsK251091 · Truvian Health · Dec 30, 2025
- CHOLESTEROL; HDL-cholesterol ; LDL-cholesterol; TRIGLYCERIDESK232404 · Medicon Hellas S.A · Aug 9, 2024
- Cholesterol2K203597 · Abbott Ireland Diagnostics Division · Jun 30, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 24, 2018
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1175
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files